Johnson and Johnson has tentatively agreed to pay up to $4 billion to settle claims brought by patients who were implanted with defective DePuy ASR artificial hips. The plan is subject to court approval and has not been formally announced. According to reports, the $4 billion settlement would be distributed amongst all patients who required replacement of their ASR hip with the per patient payout being dependent on several factors, including the patient’s age and medical condition. As more patients undergo revision surgeries to replace their failing ASR hip implants, the cost of the settlement could rise even higher. In total, approximately 60,000 patients in the U.S. received a defective ASR hip. The formal deal is likely to be announced later this week.
In addition to representing patients implanted with the recalled DePuy ASR hips, SUGARMAN has formed a team led by partners Stephen Sugarman and Benjamin Zimmermann to represent clients who have been injured as a result of defective Stryker Rejuvenate and ABG II hip implants. If you have any questions regarding a Stryker hip implant, please fill out a Contact Form, call Stephen or Ben at 617-542-1000 or email email@example.com or firstname.lastname@example.org.